Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

Heart Failure Clinical Trial

Official title:

Quantitative Evaluation of Liver Disease With Liver and Kidney Elastography Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02070315
• Other study ID #: 012-011
• Status: Active, not recruiting
• Start date: February 2012
• Est. completion date: November 2020

Study information

• Verified date: February 2020
• Source: Baylor Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.

Description:

To obtain a quantitative evaluation of the progression of liver disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine.

To compare the glomerular filtration rate and the quantitative evaluation of the progression of renal disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine in post-liver transplantation patients.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1000
• Est. completion date: November 2020
• Est. primary completion date: November 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Males and Females over the age of 18

• Patients of Liver Consultant's of Texas Dallas office, with chronic liver disease or liver transplant patient seen in Liver Transplant Clinic

• Patients diagnosed with heart failure

Exclusion Criteria:

• Any person unable to provide an informed consent

Related Conditions & MeSH terms

• Heart Failure
• Liver Disease
• Liver Diseases

Locations

Country	Name	City	State
United States	Baylor University Medical Center	Dallas	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Baylor Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Shearwave Elastography Ultrasound	Patients will have a scan performed at their regularly scheduled clinic visits.	1 day